R Michael Carruthers - Net Worth and Insider Trading
R Michael Carruthers Net Worth
The estimated net worth of R Michael Carruthers is at least $2 Million dollars as of 2025-07-23. R Michael Carruthers is the CFO of Edgewise Therapeutics Inc and owns about 81,014 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $1 Million. R Michael Carruthers is also the Exec Vice President / CFO of Alpine Immune Sciences Inc and owns about 6,000 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $389,820. Details can be seen in R Michael Carruthers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that R Michael Carruthers has not made any transactions after 2025-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of R Michael Carruthers
R Michael Carruthers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Michael Carruthers owns 5 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) , Alpine Immune Sciences Inc (ALPN) , and Edgewise Therapeutics Inc (EWTX) among others .
Click here to see the complete history of R Michael Carruthers’s form 4 insider trades.
Insider Ownership Summary of R Michael Carruthers
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2019-08-31 | Chief Financial Officer |
| ALPN | Alpine Immune Sciences Inc | 2016-12-02 | Chief Financial Officer |
| EWTX | Edgewise Therapeutics Inc | 2025-05-02 | Chief Financial Officer |
 | | 2021-06-24 | director |
| | 2024-10-04 | director |
R Michael Carruthers Latest Holdings Summary
R Michael Carruthers currently owns a total of 2 stocks. Among these stocks, R Michael Carruthers owns 81,014 shares of Edgewise Therapeutics Inc (EWTX) as of May 2, 2025, with a value of $1 Million and a weighting of 74.94%. R Michael Carruthers also owns 6,000 shares of Alpine Immune Sciences Inc (ALPN) as of December 2, 2016, with a value of $389,820 and a weighting of 25.06%.
Latest Holdings of R Michael Carruthers
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics Inc | 2025-05-02 | 81,014 | 14.39 | 1,165,791 |
| ALPN | Alpine Immune Sciences Inc | 2016-12-02 | 6,000 | 64.97 | 389,820 |
Holding Weightings of R Michael Carruthers
R Michael Carruthers Form 4 Trading Tracker
According to the SEC Form 4 filings, R Michael Carruthers has made a total of 5 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Edgewise Therapeutics Inc is the sale of 1,314 shares on May 2, 2025, which brought R Michael Carruthers around $21,615.
According to the SEC Form 4 filings, R Michael Carruthers has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the acquisition of 6,000 shares on December 2, 2016, which cost R Michael Carruthers around $50,160.
Insider Trading History of R Michael Carruthers
- 1
R Michael Carruthers Trading Performance
GuruFocus tracks the stock performance after each of R Michael Carruthers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R Michael Carruthers is 32.85%. GuruFocus also compares R Michael Carruthers's trading performance to market benchmark return within the same time period. The performance of stocks bought by R Michael Carruthers within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R Michael Carruthers's insider trading performs compared to the benchmark.
Performance of R Michael Carruthers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.21 | | | | | |
| Relative Return to S&P 500(%) | 6.07 | | | | | |
R Michael Carruthers Ownership Network
Ownership Network List of R Michael Carruthers
Ownership Network Relation of R Michael Carruthers
R Michael Carruthers Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
R Michael Carruthers is the Chief Financial Officer of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, R Michael Carruthers made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net purchase of 889,412 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 889,412 shares were bought by its insiders, resulting in a net purchase of 889,412 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
R Michael Carruthers Mailing Address
Above is the net worth, insider trading, and ownership report for R Michael Carruthers. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, R Michael Carruthers's mailing address is: Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
